简体中文 | 繁體中文 | English

Products & Services News

2020-12-09 16:36 Andersen Global Strengthens Caribbean Platform With Addition of Maurice Solomon and Co.
2020-12-09 15:20 Xlear Submits COVID-19 Pre-Emergency Use Authorization Request with FDA Regarding Use of Xlear Nasal Spray to Help in Combating SARS-CoV-2
2020-12-09 14:28 Phononic and Fabrinet Partner to Scale Global Production of High-Performance Thermoelectrics
2020-12-09 09:53 Waters Collaborates with Dr. Sunghwan Kim of Kyungpook National University to Advance Precision Analysis of Complex Chemical Compounds
2020-12-08 16:50 Esri Acquires Zibumi to Enhance 3D Visualization Capabilities
2020-12-08 15:16 Takeda Announces Approval of TAKHZYRO® (lanadelumab) subcutaneous injection in China for the Treatment of Hereditary Angioedema
2020-12-08 14:49 Bittrex Global Launches Tokenized Stock Trading
2020-12-08 14:43 P.I. Works Joins the O-RAN ALLIANCE to Drive Open Radio Access Network Innovations
2020-12-08 14:39 UVD Robots Wins EU Contract to Deploy 200 Robots in Hospitals Across Europe
2020-12-08 14:25 Sokin to use IDEMIA’s recycled plastic payment cards for all international markets
2020-12-08 10:55 New Website to Communicate Our Craftsmanship - Yamaha Motor
2020-12-08 09:55 Philip Morris International Announces U.S. Food and Drug Administration Authorization of IQOS 3 for Sale in the United States
2020-12-08 09:53 Boehringer Ingelheim Collaborates with Proxygen to Explore Molecular Glue Degraders - a Novel Approach to Fight Cancer
2020-12-07 20:22 Citi Private Bank Issues Outlook 2021: The New Economic Cycle: Investing for a Post-COVID World
2020-12-07 16:38 Jefferies Announces Co-Brand Alliance with KB Securities in South Korea
2020-12-07 16:34 PPC Upgraded to ‘B’ with ‘Stable’ Outlook by S&P
2020-12-07 16:02 Global Electronic Toll Collection and Road Usage Charging market to reach €490 billion in 2030
2020-12-07 15:58 GenesisCare Clinical CRO Adopts Veeva Vault Clinical Applications to Accelerate and Scale Studies Globally
2020-12-07 15:55 Rhizen Pharmaceuticals SA Announces Presentation of the Interim Results of the Phase I/II study of Tenalisib (RP6530) in Combination with Romidepsin in Relapsed/Refractory T-cell Lymphoma at American Society of Hematology (ASH) annual meeting, 2020
2020-12-07 09:51 New Phase 3 Data Show TAK-620 (maribavir), an Investigational Drug for the Treatment of Transplant Recipients with Refractory/Resistant Cytomegalovirus (CMV) Infections, Meets Primary Endpoint

Business Wire Weibo

Press Releases

Latest Releases